# Heart Failure Mortality Prediction Model Summary

## Executive Summary

This model predicts the likelihood of death in heart failure patients using clinical data. It demonstrates good overall performance with an ability to distinguish between patients who survive and those who do not. However, the dataset contains moderate data quality concerns, including outliers and anomalous patient records, which may affect model reliability.

## Performance

The model achieves an AUC of approximately 0.86, indicating strong capability to differentiate between patients who will experience death and those who will survive. Its accuracy is about 82%, meaning it correctly classifies the outcome in most cases. The F1 score of 0.67 reflects a balanced performance between identifying true positive cases and avoiding false alarms, which is important in clinical decision-making.

## Feature Importance

The most influential feature is 'time', representing the duration of follow-up, which strongly impacts risk prediction. Lower ejection fraction values, indicating poorer heart function, also increase risk. Elevated serum creatinine levels, a marker of kidney function, and older age are associated with higher mortality risk. Additionally, the presence of diabetes and patient sex contribute to risk assessment. Other factors like creatinine phosphokinase levels, serum sodium, smoking status, and platelet counts have smaller but meaningful effects on predictions.

## Recommendations

Before deploying this model clinically, it is important to address data quality issues by investigating outliers and anomalous records to ensure they reflect true clinical conditions. Consider data cleaning or transformation to reduce their impact. Use the model as a supportive tool alongside clinical judgment, especially given the moderate F1 score. Continuous monitoring and validation with new patient data are recommended to maintain reliability and improve performance over time.
